Last 12 months
Inside the activity.
1 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2023 Filed Jun 20, 2023 20:10 UTC |
Fotopoulos AlexandrosChief Technical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038345 · doc4.xml · derivative · entry 3 Fotopoulos Alexandros · CIK 0001799814 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: 1/4 of the RSUs vested on June 15, 2022, and the remainder vested or vests as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date. F4 · derivative.expiration_date: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 20:10 UTC |
Fotopoulos AlexandrosChief Technical Officer
|
Exercise / conversionCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038345 · doc4.xml · nonDerivative · entry 1 Fotopoulos Alexandros · CIK 0001799814 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. Read SEC document |
| May 25, 2023 Filed May 26, 2023 20:35 UTC |
Porter DerrellDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032568 · doc4.xml · derivative · entry 1 Porter Derrell · CIK 0001706400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2033-05-24 F1 · derivative.exercise_date: The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2024 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date. Read SEC document |
| May 25, 2023 Filed May 26, 2023 16:31 UTC |
Kamarck Michael E.Director
|
GrantDirector Stock Option (Right to Buy) · Derivative | 21,567 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032552 · doc4.xml · derivative · entry 1 Kamarck Michael E. · CIK 0001450730 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,567 Underlying: Common Stock · 21,567 shares Expires 2033-05-24 F1 · derivative.exercise_date: The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2024 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date. Read SEC document |
| May 25, 2023 Filed May 26, 2023 20:24 UTC |
GOWEN MAXINEDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032545 · doc4.xml · derivative · entry 1 GOWEN MAXINE · CIK 0001280044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2033-05-24 F1 · derivative.exercise_date: The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2024 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date. Read SEC document |
| May 25, 2023 Filed May 26, 2023 20:22 UTC |
Countouriotis AthenaDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032542 · doc4.xml · derivative · entry 1 Countouriotis Athena · CIK 0001571469 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2033-05-24 F1 · derivative.exercise_date: The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2024 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date. Read SEC document |
| May 25, 2023 Filed May 26, 2023 20:26 UTC |
Islam SaqibDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032546 · doc4.xml · derivative · entry 1 Islam Saqib · CIK 0001575408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2033-05-24 F1 · derivative.exercise_date: The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2024 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date. Read SEC document |
| May 25, 2023 Filed May 26, 2023 16:38 UTC |
Woiwode ThomasDirector · 10% owner
|
GrantDirector Stock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032571 · doc4.xml · derivative · entry 1 Woiwode Thomas · CIK 0001619294 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2033-05-24 F1 · derivative.exercise_date: The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2024 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date. Read SEC document |
| May 25, 2023 Filed May 26, 2023 20:34 UTC |
Kapadia SandipDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032565 · doc4.xml · derivative · entry 1 Kapadia Sandip · CIK 0001677141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2033-05-24 F1 · derivative.exercise_date: The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2024 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date. Read SEC document |
| April 18, 2023 Filed Apr 20, 2023 16:28 UTC |
King SimonaChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024982 · doc4.xml · derivative · entry 3 King Simona · CIK 0001879312 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,750 Underlying: Common Stock · 6,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: 1/4 of the RSUs vested on April 18, 2023, and the remainder will vest as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date. F4 · derivative.expiration_date: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. Read SEC document |
| April 18, 2023 Filed Apr 20, 2023 16:28 UTC |
King SimonaChief Financial Officer
|
SaleCommon Stock | 2,053 | $1.05 | $2,155.65 |
DisclosureSEC source: 0001209191-23-024982 · doc4.xml · nonDerivative · entry 2 King Simona · CIK 0001879312 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,053 F2 · kind: The sale reported on this Form 4 represents an Issuer mandated sale by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs; it does not represent a discretionary trade by the Reporting Person. Pursuant to the Issuer's equity incentive plan, an award recipient's tax withholding obligations must be funded by a "sell to cover" transaction. Read SEC document |
| April 18, 2023 Filed Apr 20, 2023 16:28 UTC |
King SimonaChief Financial Officer
|
Exercise / conversionCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024982 · doc4.xml · nonDerivative · entry 1 King Simona · CIK 0001879312 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. Read SEC document |
| March 15, 2023 Filed Apr 5, 2023 23:29 UTC |
Chou WilliamDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 608,615 | $0.00 Strike: $1.08 | $0.00 |
DisclosureSEC source: 0001209191-23-023481 · doc4.xml · derivative · entry 1 Chou William · CIK 0001949693 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 608,615 Underlying: Common Stock · 608,615 shares Expires 2033-03-14 F1 · derivative.exercise_date: The stock option vests as of 1/48 of the total shares monthly beginning on April 15, 2023 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| March 15, 2023 Filed Apr 5, 2023 19:28 UTC |
Forman Mark SChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $1.08 | $0.00 |
DisclosureSEC source: 0001209191-23-023478 · doc4.xml · derivative · entry 1 Forman Mark S · CIK 0001922353 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2033-03-14 F1 · derivative.exercise_date: The stock option vests as of 1/48 of the total shares monthly beginning on April 15, 2023 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| March 15, 2023 Filed Apr 5, 2023 19:29 UTC |
King SimonaChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 140,000 | $0.00 Strike: $1.08 | $0.00 |
DisclosureSEC source: 0001209191-23-023479 · doc4.xml · derivative · entry 1 King Simona · CIK 0001879312 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2033-03-14 F1 · derivative.exercise_date: The stock option vests as of 1/48 of the total shares monthly beginning on April 15, 2023 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| March 15, 2023 Filed Apr 5, 2023 23:27 UTC |
Cale Edgar B.GC & Corporate Secretary
|
GrantEmployee Stock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $1.08 | $0.00 |
DisclosureSEC source: 0001209191-23-023477 · doc4.xml · derivative · entry 1 Cale Edgar B. · CIK 0001799783 · GC & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2033-03-14 F1 · derivative.exercise_date: The stock option vests as of 1/48 of the total shares monthly beginning on April 15, 2023 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| March 15, 2023 Filed Apr 5, 2023 23:27 UTC |
Fotopoulos AlexandrosChief Technical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $1.08 | $0.00 |
DisclosureSEC source: 0001209191-23-023476 · doc4.xml · derivative · entry 1 Fotopoulos Alexandros · CIK 0001799814 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2033-03-14 F1 · derivative.exercise_date: The stock option vests as of 1/48 of the total shares monthly beginning on April 15, 2023 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 22:14 UTC |
Kapadia SandipDirector
|
SaleCommon Stock | 5,000 | $1.19 | $5,964.50 |
DisclosureSEC source: 0001209191-22-059462 · doc4.xml · nonDerivative · entry 1 Kapadia Sandip · CIK 0001677141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.17 to $1.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| November 22, 2022 Filed Nov 25, 2022 21:15 UTC |
Fotopoulos AlexandrosChief Technical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058795 · doc4.xml · derivative · entry 3 Fotopoulos Alexandros · CIK 0001799814 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F4 · kind: The reported transaction represents the settlement of restricted stock units which vested on June 15, 2022 but for which settlement was delayed due to an inadvertent administrative error. F5 · derivative.exercise_date: 1/4 of the RSUs vested on June 15, 2022, and the remainder will vest as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date. F6 · derivative.expiration_date: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. Read SEC document |
| November 22, 2022 Filed Nov 25, 2022 21:15 UTC |
Fotopoulos AlexandrosChief Technical Officer
|
SaleCommon Stock | 3,720 | $1.33 | $4,947.60 |
DisclosureSEC source: 0001209191-22-058795 · doc4.xml · nonDerivative · entry 2 Fotopoulos Alexandros · CIK 0001799814 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,245 F3 · kind: The sale reported on this Form 4 represents an Issuer mandated sale by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs; it does not represent a discretionary trade by the Reporting Person. Pursuant to the Issuer's equity incentive plan, an award recipient's tax withholding obligations must be funded by a "sell to cover" transaction. F2 · balance_after: The reported total includes 3,082 shares of common stock the reporting person has acquired since the date of his last ownership report through the issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d). Read SEC document |
| November 22, 2022 Filed Nov 25, 2022 21:15 UTC |
Fotopoulos AlexandrosChief Technical Officer
|
Exercise / conversionCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058795 · doc4.xml · nonDerivative · entry 1 Fotopoulos Alexandros · CIK 0001799814 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,965 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F2 · balance_after: The reported total includes 3,082 shares of common stock the reporting person has acquired since the date of his last ownership report through the issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d). Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 16:22 UTC |
Forman Mark SChief Medical Officer
|
GrantRestricted Stock Unit · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-056613 · doc4.xml · derivative · entry 1 Forman Mark S · CIK 0001922353 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F2 · derivative.exercise_date: 100% of the total RSUs will vest on December 31, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F2 · derivative.expiration_date: 100% of the total RSUs will vest on December 31, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 16:23 UTC |
King SimonaChief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-056614 · doc4.xml · derivative · entry 1 King Simona · CIK 0001879312 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F2 · derivative.exercise_date: 100% of the total RSUs will vest on December 31, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F2 · derivative.expiration_date: 100% of the total RSUs will vest on December 31, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 21:22 UTC |
Cale Edgar B.GC & Corporate Secretary
|
GrantRestricted Stock Unit · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-056611 · doc4.xml · derivative · entry 1 Cale Edgar B. · CIK 0001799783 · GC & Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F2 · derivative.exercise_date: 100% of the total RSUs will vest on December 31, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F2 · derivative.expiration_date: 100% of the total RSUs will vest on December 31, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 21:21 UTC |
Fotopoulos AlexandrosChief Technical Officer
|
GrantRestricted Stock Unit · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-056609 · doc4.xml · derivative · entry 1 Fotopoulos Alexandros · CIK 0001799814 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F2 · derivative.exercise_date: 100% of the total RSUs will vest on December 31, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F2 · derivative.expiration_date: 100% of the total RSUs will vest on December 31, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| October 10, 2022 Filed Oct 12, 2022 20:08 UTC |
Chou WilliamDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 885,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001209191-22-053454 · doc4.xml · derivative · entry 1 Chou William · CIK 0001949693 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 885,000 Underlying: Common Stock · 885,000 shares Expires 2032-10-09 F1 · derivative.exercise_date: The stock option vests as to 25% of the total shares on October 10, 2023, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| September 19, 2022 Filed Nov 18, 2022 17:01 UTC |
Toernsen Monika MariaChief Commercial Officer
|
SaleCommon Stock | 1,681 | $1.51 | $2,539.15 |
DisclosureSEC source: 0001209191-22-057891 · doc4.xml · nonDerivative · entry 2 Toernsen Monika Maria · CIK 0001873385 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,319 F2 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| September 15, 2022 Filed Nov 18, 2022 17:01 UTC |
Toernsen Monika MariaChief Commercial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-057891 · doc4.xml · derivative · entry 3 Toernsen Monika Maria · CIK 0001873385 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 5,000 shares Expires 2031-07-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer's common stock. F4 · derivative.exercise_date: 1/4 of the RSUs vested on September 15, 2022, and the remainder will vest as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date. Read SEC document |
| September 15, 2022 Filed Nov 18, 2022 17:01 UTC |
Toernsen Monika MariaChief Commercial Officer
|
Exercise / conversionCommon Stock | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-057891 · doc4.xml · nonDerivative · entry 1 Toernsen Monika Maria · CIK 0001873385 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 20:32 UTC |
Kamarck Michael E.Director
|
GrantStock Option (right to buy) · Derivative | 48,000 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001209191-22-041401 · doc4.xml · derivative · entry 1 Kamarck Michael E. · CIK 0001450730 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 Underlying: Common Stock · 48,000 shares Expires 2032-07-04 F1 · derivative.exercise_date: The stock option vests as of 1/36 of the total shares monthly beginning on July 5, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 17:24 UTC |
Forman Mark SChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 136,000 | $0.00 Strike: $2.29 | $0.00 |
DisclosureSEC source: 0001209191-22-037053 · doc4.xml · derivative · entry 1 Forman Mark S · CIK 0001922353 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,000 Underlying: Common Stock · 136,000 shares Expires 2032-06-12 F1 · derivative.exercise_date: The stock option vests as of 1/36 of the total shares monthly beginning on July 13, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 17:25 UTC |
King SimonaChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 159,000 | $0.00 Strike: $2.29 | $0.00 |
DisclosureSEC source: 0001209191-22-037054 · doc4.xml · derivative · entry 1 King Simona · CIK 0001879312 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,000 Underlying: Common Stock · 159,000 shares Expires 2032-06-12 F1 · derivative.exercise_date: The stock option vests as of 1/36 of the total shares monthly beginning on July 13, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 17:33 UTC |
Toernsen Monika MariaChief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 101,000 | $0.00 Strike: $2.29 | $0.00 |
DisclosureSEC source: 0001209191-22-037060 · doc4.xml · derivative · entry 1 Toernsen Monika Maria · CIK 0001873385 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,000 Underlying: Common Stock · 101,000 shares Expires 2032-06-12 F1 · derivative.exercise_date: The stock option vests as of 1/36 of the total shares monthly beginning on July 13, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 21:22 UTC |
Cale Edgar B.Interim CEO, GC & Corp. Sec.
|
GrantEmployee Stock Option (right to buy) · Derivative | 106,000 | $0.00 Strike: $2.29 | $0.00 |
DisclosureSEC source: 0001209191-22-037051 · doc4.xml · derivative · entry 1 Cale Edgar B. · CIK 0001799783 · Interim CEO, GC & Corp. Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,000 Underlying: Common Stock · 106,000 shares Expires 2032-06-12 F1 · derivative.exercise_date: The stock option vests as of 1/36 of the total shares monthly beginning on July 13, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 21:21 UTC |
Fotopoulos AlexandrosChief Technical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $2.29 | $0.00 |
DisclosureSEC source: 0001209191-22-037050 · doc4.xml · derivative · entry 1 Fotopoulos Alexandros · CIK 0001799814 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2032-06-12 F1 · derivative.exercise_date: The stock option vests as of 1/36 of the total shares monthly beginning on July 13, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| May 31, 2022 Filed Jun 1, 2022 20:27 UTC |
GOWEN MAXINEDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001209191-22-033163 · doc4.xml · derivative · entry 1 GOWEN MAXINE · CIK 0001280044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-05-30 F1 · derivative.exercise_date: The stock option vests in ratable increments of 1/12 of the total award on each monthly anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on each vesting date. Read SEC document |
| May 31, 2022 Filed Jun 1, 2022 20:17 UTC |
Cale Edgar B.Interim CEO, GC & Corp. Sec.
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001209191-22-033149 · doc4.xml · derivative · entry 1 Cale Edgar B. · CIK 0001799783 · Interim CEO, GC & Corp. Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-05-30 F1 · derivative.exercise_date: The stock option vests in ratable increments of 1/12 of the total award on each monthly anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on each vesting date. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:25 UTC |
Goldsmith Bruce ADirector · CEO and President
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001209191-22-033158 · doc4.xml · derivative · entry 1 Goldsmith Bruce A · CIK 0001500322 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-05-26 F1 · derivative.exercise_date: The stock option vests in full on September 1, 2022, subject to the reporting person's continuous service to the issuer on such date. Read SEC document |
| May 26, 2022 Filed May 31, 2022 20:32 UTC |
Porter DerrellDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0001209191-22-032837 · doc4.xml · derivative · entry 1 Porter Derrell · CIK 0001706400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2032-05-25 F1 · derivative.exercise_date: The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date. Read SEC document |
| May 26, 2022 Filed May 31, 2022 20:22 UTC |
GOWEN MAXINEDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0001209191-22-032812 · doc4.xml · derivative · entry 1 GOWEN MAXINE · CIK 0001280044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2032-05-25 F1 · derivative.exercise_date: The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date. Read SEC document |
| May 26, 2022 Filed May 31, 2022 20:20 UTC |
Countouriotis AthenaDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0001209191-22-032807 · doc4.xml · derivative · entry 1 Countouriotis Athena · CIK 0001571469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2032-05-25 F1 · derivative.exercise_date: The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date. Read SEC document |
| May 26, 2022 Filed May 31, 2022 20:25 UTC |
Islam SaqibDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0001209191-22-032819 · doc4.xml · derivative · entry 1 Islam Saqib · CIK 0001575408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2032-05-25 F1 · derivative.exercise_date: The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date. Read SEC document |
| May 26, 2022 Filed May 31, 2022 16:33 UTC |
Woiwode ThomasDirector · 10% owner
|
GrantDirector Stock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0001209191-22-032839 · doc4.xml · derivative · entry 1 Woiwode Thomas · CIK 0001619294 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2032-05-25 F1 · derivative.exercise_date: The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date. Read SEC document |
| May 26, 2022 Filed May 31, 2022 20:28 UTC |
Kapadia SandipDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0001209191-22-032825 · doc4.xml · derivative · entry 1 Kapadia Sandip · CIK 0001677141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2032-05-25 F1 · derivative.exercise_date: The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date. Read SEC document |
| May 04, 2022 Filed May 5, 2022 21:23 UTC |
ORBIMED ADVISORS LLC10% owner
OrbiMed Capital GP VII LLC10% owner
|
PurchaseCommon Stock | 303,500 | $1.94 | $588,790.00 |
DisclosureSEC source: 0000947871-22-000509 · ownership.xml · nonDerivative · entry 2 ORBIMED ADVISORS LLC · CIK 0001055951 · 10% owner OrbiMed Capital GP VII LLC · CIK 0001760648 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 6,841,423 F2 · price: These Shares were purchased in multiple transactions at prices ranging from $1.93 to $2.14. The price reported reflects the weighted average purchase price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: The Shares are held of record by OrbiMed Private Investments VII, LP ("OPI VII"). OrbiMed Capital GP VII LLC ("GP VII") is the general partner of OPI VII and OrbiMed Advisors LLC ("OrbiMed Advisors"), a registered investment adviser under the Investment Advisors Act of 1940, as amended, is the managing member of GP VII. By virtue of such relationship, OrbiMed Advisors and GP VII may be deemed to have voting power and investment power over the securities held by OPI VII and, as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the Shares held by OPI VII. F4 · ownership.nature: Each of GP VII and OrbiMed Advisors disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report on Form 4 shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| May 03, 2022 Filed May 5, 2022 21:23 UTC |
ORBIMED ADVISORS LLC10% owner
OrbiMed Capital GP VII LLC10% owner
|
PurchaseCommon Stock | 221,500 | $1.93 | $427,495.00 |
DisclosureSEC source: 0000947871-22-000509 · ownership.xml · nonDerivative · entry 1 ORBIMED ADVISORS LLC · CIK 0001055951 · 10% owner OrbiMed Capital GP VII LLC · CIK 0001760648 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 6,537,923 F1 · price: These shares of the Issuer's common stock ("Shares") were purchased in a block order at a price of $1.93. F3 · ownership.nature: The Shares are held of record by OrbiMed Private Investments VII, LP ("OPI VII"). OrbiMed Capital GP VII LLC ("GP VII") is the general partner of OPI VII and OrbiMed Advisors LLC ("OrbiMed Advisors"), a registered investment adviser under the Investment Advisors Act of 1940, as amended, is the managing member of GP VII. By virtue of such relationship, OrbiMed Advisors and GP VII may be deemed to have voting power and investment power over the securities held by OPI VII and, as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the Shares held by OPI VII. F4 · ownership.nature: Each of GP VII and OrbiMed Advisors disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report on Form 4 shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 16:22 UTC |
Forman Mark SChief Medical Officer
|
GrantEmployee Stock Options (right to buy) · Derivative | 136,000 | $0.00 Strike: $2.61 | $0.00 |
DisclosureSEC source: 0001209191-22-024938 · doc4.xml · derivative · entry 1 Forman Mark S · CIK 0001922353 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,000 Underlying: Common Stock · 136,000 shares Expires 2032-04-17 F1 · derivative.exercise_date: The stock option vests as to 25% of the total shares on April 18, 2023, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 16:23 UTC |
King SimonaChief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-024942 · doc4.xml · derivative · entry 1 King Simona · CIK 0001879312 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F2 · derivative.exercise_date: 1/4 of the RSUs will vest on April 18, 2023, and the remainder will vest as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date. F2 · derivative.expiration_date: 1/4 of the RSUs will vest on April 18, 2023, and the remainder will vest as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 16:43 UTC |
Goldsmith Bruce ADirector · CEO and President
|
PurchaseCommon Stock | 10,000 | $3.15 | $31,500.00 |
DisclosureSEC source: 0001209191-22-020791 · doc4.xml · nonDerivative · entry 1 Goldsmith Bruce A · CIK 0001500322 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,983 Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 17:05 UTC |
King SimonaChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 159,000 | $0.00 Strike: $4.52 | $0.00 |
DisclosureSEC source: 0001787297-22-000003 · primary_doc.xml · derivative · entry 1 King Simona · CIK 0001879312 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,000 Underlying: Common Stock · 159,000 shares Expires 2032-02-09 F1 · derivative.exercise_date: The stock option vests as to 1/48 of the total shares monthly beginning on March 10, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.